Duke University Health System Develops Early Alzheimer's Nasal Swab

Duke University Health System researchers have developed a novel, non-invasive nasal swab test capable of detecting early biological changes associated with Alzheimer s disease, even before the onset of memory loss. Published in Nature Communications, the study involved collecting nerve and immune cells from the upper part of the nose, which are directly linked to the brain. Analysis of gene activity in these cells revealed distinct patterns that could differentiate individuals with early or diagnosed Alzheimer's from healthy controls with approximately 81% accuracy. This method offers a more direct and earlier diagnostic tool compared to current blood tests, which detect markers later in the disease progression. The research, led by Bradley J. Goldstein and Vincent M. D Anniballe, was funded by the United States===National Institutes of Health and is being expanded to larger study groups to track treatment efficacy. This advancement holds significant promise for early intervention and improved patient outcomes for Alzheimer s disease.